NCT06325787Completed
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
Long-term Comparison of Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study
Source: ClinicalTrials.gov · Last updated 25 Mar 2024
Brief summary (registry, in English)
To evaluate the clinical outcomes of image-guided thermal ablation versus thyroid lobectomy for the treatment of papillary thyroid microcarcinoma
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1021 (actual)
- First submitted
- 16 Mar 2024
- Start date
- May 2013
- Primary completion date
- Jan 2017
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT06325787
What you commit to
- Study type: Interventional
- Participants enrolled: 1021
- From May 2013 to the primary completion date, Jan 2017
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- (1)aggressive subtype of papillary thyroid microcarcinoma confirmed by biopsy(1); (2)multiple tumors; (3) incomplete data or lost follow-up
Who the study is looking for
- solitary papillary thyroid carcinoma confirmed by fine-needle aspiration or core-needle biopsy;
- largest diameter ≤10 mm;
- no evidence of extrathyroidal extension( no signs of unsmooth thyroid capsule or involvement of the perithyroidal tissue) on ultrasound;
- no evidence of cervical lymph node metastasis on US or neck CT;
- no distant metastasis on chest CT;
- no history of neck irradiation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.